Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 2
Hospital pilot program for domestic PPE purchasing
Requires certain high-Medicare-reimbursement hospitals to buy at least 40% of their personal protective equipment (PPE) and medical consumables from U.S. manufacturers, with penalties for noncompliance and reimbursement for compliant purchases. Directs the President to impose tariffs rising to 300% on imported personal protective equipment (PPE) and medical consumables, phased in over five years, to make domestically produced goods more price-competitive.
- Population Scope Medium Directly binds large hospitals receiving above-average Medicare payments — a significant but bounded subset of U.S. hospitals — plus importers and domestic manufacturers affected by 300% tariffs on PPE and medical consumables.
- Budgetary Magnitude High Mandatory annual reimbursement to compliant hospitals for the full dollar value of domestic PPE purchases, funded by tariff revenue transferred to the Department of Health and Human Services (HHS), creates a large recurring federal expenditure tied to hospital procurement volumes across the Medicare system.
- Legal / Regulatory Depth High Creates new statutory mandates — a domestic purchasing floor enforceable through Medicare reimbursement reductions and a presidential tariff proclamation rising to 300% — representing new enforceable obligations imposed on both hospitals and importers that fundamentally alter existing purchasing and trade law.
- Degree of Discretion Granted Medium The Secretary of HHS receives authority to adjust the 40% purchasing threshold during emergencies and to develop attestation forms and program administration rules, while the President is directed by mandatory proclamation language on tariff levels, balancing bounded discretion with firm statutory floors.
- Implementation & Enforcement Burden High Imposes standing compliance infrastructure — annual cost-report data submissions, manufacturer attestations under penalty of perjury, and an escalating Medicare payment-reduction regime requiring ongoing monitoring and adjudication across all participating hospitals.
- Temporal Commitment High Both the purchasing mandate and the tariff persist indefinitely — penalties survive program termination, the tariff has no sunset, and neither provision forces a future Congressional revisit — binding future actors until Congress acts to repeal them.
No signal yet
Core Policy Mechanism Top 2
Per-unit production tax credit for domestic PPE
Creates a new federal tax credit for U.S. manufacturers that produce and sell qualifying personal protective equipment (PPE), with per-item credit amounts ranging from a few cents for gloves to hundreds of dollars for ventilators, expiring after 2035. Creates a 20% federal tax credit for businesses that invest in new personal protective equipment (PPE) manufacturing facilities in the United States, subject to domestic content requirements, expiring after 2035.
- Population Scope Low Directly affects only domestic PPE manufacturers and businesses investing in PPE manufacturing facilities — a narrow industrial population well under 10% of U.S. entities.
- Budgetary Magnitude Medium Both credits reduce federal tax receipts on a recurring basis through 2035 — per-unit production credits across a specialized manufacturing sector plus a 20% investment credit on facility capital expenditures — likely reaching billions over the credit period but confined to a limited industrial base.
- Legal / Regulatory Depth High Creates two new Internal Revenue Code sections (§45BB and §48F) establishing enforceable tax entitlements — new statutory rights that directly alter manufacturers' and investors' legal and financial positions under federal tax law.
- Degree of Discretion Granted Low Credit amounts, domestic content thresholds, and eligibility conditions are fixed by statute, leaving Department of Health and Human Services (HHS) only a certification role and the IRS standard administrative authority, with no meaningful rulemaking discretion over core credit parameters.
- Implementation & Enforcement Burden Medium Requires recurring HHS safety certification, domestic content verification, and the IRS administration of two distinct credit regimes including a coordination rule barring dual claims — a moderate ongoing compliance and verification burden on manufacturers and tax authorities.
- Temporal Commitment Low Both credits expire by statute on December 31, 2035 — a hard sunset within 10 years that self-terminates the obligation unless Congress affirmatively acts to extend it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill aims to boost domestic manufacturing of personal protective equipment (PPE) and medical supplies through several coordinated federal policy tools. It uses hospital purchasing rules, import tariffs, and tax incentives to shift production back to the United States. Among other elements, the bill * creates a pilot program requiring certain large Medicare-funded hospitals to buy at least 40% of their PPE and medical consumables from U.S. makers, with financial penalties for hospitals that do not comply; * imposes steep tariffs — rising to 300% — on imported PPE and medical consumables to make domestic goods more competitive; * provides a per-unit tax credit for U.S. manufacturers that produce and sell qualifying PPE items; * and offers a 20% tax credit for businesses that invest in PPE manufacturing facilities in the United States.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Sep 24, 2026
|
Sep 24, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 2
Hospital pilot program for domestic PPE purchasing
Requires certain high-Medicare-reimbursement hospitals to buy at least 40% of their personal protective equipment (PPE) and medical consumables from U.S. manufacturers, with penalties for noncompliance and reimbursement for compliant purchases. Directs the President to impose tariffs rising to 300% on imported personal protective equipment (PPE) and medical consumables, phased in over five years, to make domestically produced goods more price-competitive.
- Population Scope Medium Directly binds large hospitals receiving above-average Medicare payments — a significant but bounded subset of U.S. hospitals — plus importers and domestic manufacturers affected by 300% tariffs on PPE and medical consumables.
- Budgetary Magnitude High Mandatory annual reimbursement to compliant hospitals for the full dollar value of domestic PPE purchases, funded by tariff revenue transferred to the Department of Health and Human Services (HHS), creates a large recurring federal expenditure tied to hospital procurement volumes across the Medicare system.
- Legal / Regulatory Depth High Creates new statutory mandates — a domestic purchasing floor enforceable through Medicare reimbursement reductions and a presidential tariff proclamation rising to 300% — representing new enforceable obligations imposed on both hospitals and importers that fundamentally alter existing purchasing and trade law.
- Degree of Discretion Granted Medium The Secretary of HHS receives authority to adjust the 40% purchasing threshold during emergencies and to develop attestation forms and program administration rules, while the President is directed by mandatory proclamation language on tariff levels, balancing bounded discretion with firm statutory floors.
- Implementation & Enforcement Burden High Imposes standing compliance infrastructure — annual cost-report data submissions, manufacturer attestations under penalty of perjury, and an escalating Medicare payment-reduction regime requiring ongoing monitoring and adjudication across all participating hospitals.
- Temporal Commitment High Both the purchasing mandate and the tariff persist indefinitely — penalties survive program termination, the tariff has no sunset, and neither provision forces a future Congressional revisit — binding future actors until Congress acts to repeal them.
No signal yet
Core Policy Mechanism
Hospital pilot program for domestic PPE purchasing
Core Policy Mechanism Top 2
Per-unit production tax credit for domestic PPE
Creates a new federal tax credit for U.S. manufacturers that produce and sell qualifying personal protective equipment (PPE), with per-item credit amounts ranging from a few cents for gloves to hundreds of dollars for ventilators, expiring after 2035. Creates a 20% federal tax credit for businesses that invest in new personal protective equipment (PPE) manufacturing facilities in the United States, subject to domestic content requirements, expiring after 2035.
- Population Scope Low Directly affects only domestic PPE manufacturers and businesses investing in PPE manufacturing facilities — a narrow industrial population well under 10% of U.S. entities.
- Budgetary Magnitude Medium Both credits reduce federal tax receipts on a recurring basis through 2035 — per-unit production credits across a specialized manufacturing sector plus a 20% investment credit on facility capital expenditures — likely reaching billions over the credit period but confined to a limited industrial base.
- Legal / Regulatory Depth High Creates two new Internal Revenue Code sections (§45BB and §48F) establishing enforceable tax entitlements — new statutory rights that directly alter manufacturers' and investors' legal and financial positions under federal tax law.
- Degree of Discretion Granted Low Credit amounts, domestic content thresholds, and eligibility conditions are fixed by statute, leaving Department of Health and Human Services (HHS) only a certification role and the IRS standard administrative authority, with no meaningful rulemaking discretion over core credit parameters.
- Implementation & Enforcement Burden Medium Requires recurring HHS safety certification, domestic content verification, and the IRS administration of two distinct credit regimes including a coordination rule barring dual claims — a moderate ongoing compliance and verification burden on manufacturers and tax authorities.
- Temporal Commitment Low Both credits expire by statute on December 31, 2035 — a hard sunset within 10 years that self-terminates the obligation unless Congress affirmatively acts to extend it.
No signal yet
Core Policy Mechanism
Per-unit production tax credit for domestic PPE
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: